Although most people who recovered from COVID-19 had low levels of antibodies to SARS-CoV-2 in their blood, researchers identified potent infection-blocking antibodies.
Specific gut bacteria influenced eating decisions in worms by affecting their response to odors. The findings give insight into one way gut microbes may affect behavior.
June 2, 2020 —
Early clinical trial results support the use of remdesivir for patients with severe COVID-19 who require supplemental oxygen, but more research is needed to improve outcomes for people with COVID-19.
June 2, 2020 —
Scientists identified a group of neurons in mice that blunt pain within the brain. Such neurons could be promising targets for new non-addictive therapies for chronic pain.
May 19, 2020 —
Based on antibodies isolated from llamas, researchers engineered an antibody that prevented SARS-CoV-2, the virus that causes COVID-19, from entering cells in laboratory experiments.
May 19, 2020 —
Obese mice lost weight and showed improved metabolic function when treated with a drug that’s normally prescribed for alcohol use disorder.
May 19, 2020 —
A new study suggests that an immune-related protein found in higher levels in men helps protect against certain autoimmune diseases but increases the risk of schizophrenia.
May 12, 2020 —
Damage to the blood-brain barrier may contribute to the development of Alzheimer’s dementia in people carrying a high-risk gene variation.
May 12, 2020 —
Progress in understanding how the prostate regenerates after hormone therapy may one day lead to improved therapies for prostate cancer.
